Search results for "Dizziness"
Extended-release metformin recalled due to impurity
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/07/extended-release-metformin-recalled-due-to-impurity.htm
1 Jul 2020
New warning on NSAIDs; drug approved for flu exposures
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/01/new-warning-on-nsaids-drug-approved-for-flu-exposures.htm
1 Jan 2021
Warnings about topical antiseptics, nuclear stress test agents
This regulatory update covers label and packaging changes to over-the-counter topical antiseptic products due to infection risk and approval of the first generic versions of rabeprazole sodium for gastroesophageal reflux disease.
https://immattersacp.org/archives/2014/02/fda.htm
1 Feb 2014
Weight-loss drug and at-home HIV test approved
This regulatory update covers approval of lorcaserin HCl for chronic weight management, as well as a new at-home mouth swab test for HIV 1 and 2.
https://immattersacp.org/archives/2012/09/fda.htm
1 Sep 2012
FDA warns about clarithromycin in heart disease
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/05/fda-warns-about-clarithromycin-in-heart-disease.htm
1 May 2018
Cardiac risks of testosterone, saxagliptin under investigation
This regulatory update covers an FDA review of the risk of stroke, heart attack and death in men taking testosterone products, as well as a possible increase in heart failure associated with saxagliptin.
https://immattersacp.org/archives/2014/04/fda.htm
1 Apr 2014
Risks seen with anemia, asthma drugs; insulin syringes recalled
Warnings, recalls and updates from the Food and Drug Administration.
https://immattersacp.org/archives/2010/04/fda.htm
1 Apr 2010
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
New CBC test, implant for apnea approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/01/new-cbc-test-implant-for-apnea-approved.htm
1 Jan 2018
New warnings on acetaminophen, ketoconazole
This regulatory update covers a rare but serious skin reaction for acetaminophen, as well as new limits on ketoconazole due to risks of liver injury.
https://immattersacp.org/archives/2013/10/fda.htm
1 Oct 2013